{"id":8038,"date":"2018-01-08T12:36:43","date_gmt":"2018-01-08T17:36:43","guid":{"rendered":"https:\/\/fomatmedical.com\/?p=8038"},"modified":"2026-04-23T20:27:41","modified_gmt":"2026-04-24T03:27:41","slug":"effect-of-medicine","status":"publish","type":"post","link":"https:\/\/fomatmedical.com\/es\/blogs-updates\/effect-of-medicine\/","title":{"rendered":"Las distintas mutaciones humanas pueden alterar el efecto de los medicamentos."},"content":{"rendered":"<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">The effect of medicine can vary significantly from person to person due to distinct human DNA mutations. Every person has a unique DNA sequence, and a study published in the scientific journal <a class=\"underline underline underline-offset-2 decoration-1 decoration-current\/40 hover:decoration-current focus:decoration-current\" href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5766829\/\" target=\"_blank\" rel=\"noopener\">Cell<\/a> examines certain receptors known as GPCRs in human cells. These protein receptors are the primary targets of the largest group of marketed modern medicines.<\/p>\n<h3 class=\"text-text-100 mt-3 -mb-1 text-[1.125rem] font-bold\">How Human Mutations Alter the Effect of Medicine<\/h3>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">By mining existing datasets, researchers have mapped the extent to which mutations occur within GPCR drug targets in individuals and studied what impact these mutations could have on the therapeutic effect of medicine.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">&#8220;We estimate that an average of 3 percent of the population have receptors that contain mutations that can alter the effect of medicine,&#8221; says first author Alexander Hauser from the Department of Drug Design and Pharmacology at the University of Copenhagen.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">&#8220;This might mean that the medicine simply works less efficiently. It can also mean that the medicine does not work at all, or causes adverse effects on patients,&#8221; adds Madan Babu from the MRC Lab of Molecular Biology in Cambridge, where Hauser conducted this research.<\/p>\n<h3 class=\"text-text-100 mt-3 -mb-1 text-[1.125rem] font-bold\">The Research Behind These Findings<\/h3>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">The researchers analyzed mutations in human GPCRs using whole genome sequencing data from the 1,000 Genomes project with approximately 2,500 participants, as well as exome data from the ExAC project with over 60,000 participants. They then used structural data to identify critical sites in GPCRs to uncover which mutations are most likely to alter the effect of medicine on patients.<\/p>\n<h3 class=\"text-text-100 mt-3 -mb-1 text-[1.125rem] font-bold\">Which Receptors Show the Greatest Effect of Medicine Variation<\/h3>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">The 3 percent figure represents an average across the population. For some important receptors, the impact on the effect of medicine is far greater:<\/p>\n<ul class=\"[li_&amp;]:mb-0 [li_&amp;]:mt-1 [li_&amp;]:gap-1 [&amp;:not(:last-child)_ul]:pb-1 [&amp;:not(:last-child)_ol]:pb-1 list-disc flex flex-col gap-1 pl-8 mb-3\">\n<li class=\"whitespace-normal break-words pl-2\">In the GLP1 receptor \u2014 a target of diabetes medicine \u2014 relevant mutations occur in <strong>69 percent<\/strong> of people<\/li>\n<li class=\"whitespace-normal break-words pl-2\">In the CNR2 receptor \u2014 used as a target for medicine to relieve nausea induced by chemotherapy \u2014 mutations occur in <strong>86 percent<\/strong> of people<\/li>\n<\/ul>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">&#8220;But of course, we cannot know every person&#8217;s genome, and so these are estimates based on the datasets available,&#8221; says Alexander Hauser.<\/p>\n<h3 class=\"text-text-100 mt-3 -mb-1 text-[1.125rem] font-bold\">The Economic Cost of Altered Medicine Effects<\/h3>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">The researchers used their findings alongside sales data for 279 GPCR relevant drugs from the National Health Service in the UK to estimate how much money is spent on medicine with little or no effect due to human mutations. As a conservative estimate, the economic burden on the UK National Health Service is at least \u00a314 million annually, taking into account the number of people with mutations in both copies of the gene in important receptor target sites.<\/p>\n<h3 class=\"text-text-100 mt-3 -mb-1 text-[1.125rem] font-bold\">Personalized Medicine and the Future Effect of Medicine Research<\/h3>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">&#8220;The prevalence and potential impact of variation in drug response between individuals is a strong argument for further researching this field. It also constitutes a fine example of why personalized medicine might be the way forward, even when we are talking about common drugs,&#8221; says Hauser.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Understanding how human mutations alter the effect of medicine is a core reason why diverse participation in clinical trials matters. When study populations reflect the full range of human genetic variation, researchers can better identify how individual differences affect drug response across communities. At FOMAT, our commitment to inclusive clinical research ensures that participants from all backgrounds contribute to findings that lead to more effective and personalized treatments for everyone. If you are interested in contributing to this kind of research, visit our <a class=\"underline underline underline-offset-2 decoration-1 decoration-current\/40 hover:decoration-current focus:decoration-current\" href=\"#\">active studies page<\/a> to learn more about current clinical trials enrolling now.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>El efecto de los medicamentos puede variar considerablemente de una persona a otra debido a las distintas mutaciones del ADN humano. Cada persona tiene una secuencia de ADN \u00fanica, y un estudio publicado en la revista cient\u00edfica Cell analiza ciertos receptores conocidos como GPCR en los seres humanos\u2026<\/p>","protected":false},"author":3,"featured_media":87542,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[968],"tags":[],"class_list":["post-8038","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blogs-updates"],"acf":[],"_links":{"self":[{"href":"https:\/\/fomatmedical.com\/es\/wp-json\/wp\/v2\/posts\/8038","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fomatmedical.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fomatmedical.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fomatmedical.com\/es\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/fomatmedical.com\/es\/wp-json\/wp\/v2\/comments?post=8038"}],"version-history":[{"count":0,"href":"https:\/\/fomatmedical.com\/es\/wp-json\/wp\/v2\/posts\/8038\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fomatmedical.com\/es\/wp-json\/wp\/v2\/media\/87542"}],"wp:attachment":[{"href":"https:\/\/fomatmedical.com\/es\/wp-json\/wp\/v2\/media?parent=8038"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fomatmedical.com\/es\/wp-json\/wp\/v2\/categories?post=8038"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fomatmedical.com\/es\/wp-json\/wp\/v2\/tags?post=8038"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}